Hello, I’m Anil Busimi, Head of Global Product Management in SCHOTT’s syringe division. I joined SCHOTT in 2003, and have since held a number of different positions, including Business Development Manager for microarrays, Consultant in corporate strategy and development, and Strategic Business Manager for the global pharmaceutical packaging division. I was the Global Product Manager for SCHOTT’s TopPac syringes before taking on my current role. I hold a master’s degree in agriculture and genetics, as well as an MBA.
There’s been a shift in global medicine, and its ripples continue to spread. New drug development in traditional markets has slowed, and specialty drugs – typically biologics used for conditions ... read more
It’s a question we hear again and again. A question that has greater importance for pharmaceutical manufacturers as the popularity of prefilled syringes (PFSs) continues to rise, and manufacturers ... read more
Glass is the gold standard for parenteral packaging, especially in the prefilled syringe (PFS) market, where it represents 95 percent of all applications. But glass isn’t the only solution on the ... read more
More than half of all drug candidates in development today are biotech-based drugs and are generally only administered by injection. Prefilled syringe (PFS) usage in particular continues to grow ... read more